|By PR Newswire||
|April 9, 2014 12:48 PM EDT||
LONDON, April 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
EpiCast Report: Diabetic Neuropathy - Epidemiology Forecast to 2022
Diabetic neuropathy affects an estimated 50% of patients with diabetes and is one of the leading causes of morbidity in diabetic patients, often leading to foot ulcerations or amputation. Diabetic neuropathy is clinically defined as "the presence of symptoms and/or signs of peripheral nerve dysfunction in people with diabetes after the exclusion of other causes" (Argoff et al., 2006; Boulton et al., 1998).
According to the epidemiologic literature, poor glycemic control, age, duration of diabetes, and obesity are risk factors for diabetic neuropathy (Abbott et al., 2011; Adler et al., 1997; Argoff et al., 2006; Tesfaye and Selvarajah, 2012). However, diabetic neuropathy is considered to be part of the natural progression of diabetes as a microvascular complication of the disease.
GlobalData epidemiologists forecast that the total prevalent cases of diabetic neuropathy in the diagnosed diabetic population in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan) will increase from 13,842,033 cases in 2012 to 19,783,289 cases in 2022 at an Annual Growth Rate (AGR) of 4.29%. Throughout the forecast period, the US will have the highest number of total prevalent diabetic neuropathy cases in the diagnosed diabetic population, with approximately 45% of the cases. The increase in the number of total prevalent cases of diabetic neuropathy in the 7MM is the result of changing population demographics and GlobalData's predicted increase in the diagnosed prevalent cases of diabetes in the 7MM.
- The diabetic neuropathy EpiCast Report provides an overview of the risk factors and epidemiological trends for diabetic neuropathy in the seven major markets (6MM) (US, France, Germany, Italy, Spain, and UK). It includes a 10-year epidemiological forecast of the total prevalent cases of diabetic neuropathy in the diagnosed diabetic population segmented by age, (adults over the age of 40 years), sex, and the proportion of comorbid hypertension prevalent case in these markets.
- The diabetic neuropathy epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
Reasons to buy
- Develop business strategies by understanding the trends shaping and driving the global DFU market.
- Quantify patient populations in the global diabetic neuropathy market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for diabetic neuropathy therapeutics in each of the markets covered.
Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
3 Epidemiology 8
3.1 Disease Background 8
3.2 Risk Factors and Comorbidities 9
3.3 Global Trends 9
3.3.1 US 10
3.3.2 5EU 11
3.3.3 Japan 12
3.4 Epidemiological Forecast for Diabetic Neuropathy (2012-2022) 13
3.4.1 Forecast Methodology 13
3.4.2 Sources Used 14
3.4.3 Sources Not Used 17
3.4.4 Forecast Assumptions and Methods — Diagnosed Prevalent Cases of Diabetes 19
3.4.5 Forecast Assumptions and Methods — Diabetic Neuropathy 23
3.5 Epidemiology Forecast for Diabetic Neuropathy (2012-2022) 25
3.5.1 Diabetic Neuropathy 25
3.5.2 Total Prevalent Cases of Diabetic Neuropathy by Age 27
3.5.3 Total Prevalent Cases of Diabetic Neuropathy by Sex 29
3.5.4 Total Prevalent Cases of Diabetic Neuropathy, Comorbid Hypertension 31
3.6 Discussion 32
3.6.1 Conclusions on Epidemiological Trends 32
3.6.2 Limitations of the Analysis 34
3.6.3 Strengths of the Analysis 35
4 Appendix 36
4.1 Bibliography 36
4.2 About the Authors 41
4.2.1 Epidemiologists 41
4.2.2 Reviewers 41
4.2.3 Global Director of Epidemiology and Health Policy 42
4.2.4 Global Head of Healthcare 42
4.3 About GlobalData 43
4.4 About EpiCast 43
4.5 Disclaimer 43
List of Tables
Table 1: Neuropathic Pain Descriptor Terms 8
Table 2: 7MM, Sources of Diabetic Neuropathy Total Prevalence Data 13
Table 3: 7MM, Excluded Sources of Diabetic Neuropathy Total Prevalence Data 17
Table 4: 7MM, Total Prevalent Cases of Diabetic Neuropathy in Diagnosed Diabetics, Both Sexes, Ages ? 40 Years, N, 2012-2022 25
Table 5: 7MM, Total Prevalent Cases of Diabetic Neuropathy in Diagnosed Diabetics, Both Sexes, by Age, N, Row (%), 2012 27
Table 6: 7MM, Total Prevalent Cases of Diabetic Neuropathy in Diagnosed Diabetics, by Sex, Ages ? 40 Years, N, Row (%), 2012 29
List of Figures
Figure 1: 7MM, Total Prevalent Cases of Diabetic Neuropathy in Diagnosed Diabetics, Both Sexes, Ages ? 40 Years, N, 2012-2022 26
Figure 2: 7MM, Total Prevalent Cases of Diabetic Neuropathy in Diagnosed Diabetics, Both Sexes, by Age, N, 2012 28
Figure 3: 7MM, Total Prevalent Cases of Diabetic Neuropathy in Diagnosed Diabetics, by Sex, Ages ? 40 Years, N, 2012 30
Figure 4: 7MM, Comorbid Hypertension in Diabetic Neuropathy Cases (N), Both Sexes, Ages 40+, 2012 31
Read the full report:
EpiCast Report: Diabetic Neuropathy - Epidemiology Forecast to 2022
May. 5, 2016 12:00 PM EDT Reads: 429
May. 5, 2016 11:30 AM EDT Reads: 665
May. 5, 2016 11:30 AM EDT Reads: 1,100
May. 5, 2016 11:15 AM EDT Reads: 1,114
May. 5, 2016 10:15 AM EDT Reads: 1,547
May. 5, 2016 10:15 AM EDT Reads: 998
May. 5, 2016 10:00 AM EDT Reads: 1,448
May. 5, 2016 09:30 AM EDT Reads: 1,461
May. 5, 2016 09:00 AM EDT Reads: 1,175
May. 5, 2016 09:00 AM EDT Reads: 1,255
May. 5, 2016 08:45 AM EDT Reads: 1,381
May. 5, 2016 08:30 AM EDT Reads: 720
Unless you don’t use the internet, don’t live in California, or haven’t been paying attention to the recent news… you should be aware that self-driving cars are on their way to becoming a reality. I have seen them – they are real. If you believe in the future reality of self-driving cars, then continue reading on. If you don’t believe in the future possibilities, then I am not sure what to do to convince you other than discuss the very real changes that will roll out with the consumer producti...
May. 5, 2016 07:30 AM EDT Reads: 864
We’ve worked with dozens of early adopters across numerous industries and will debunk common misperceptions, which starts with understanding that many of the connected products we’ll use over the next 5 years are already products, they’re just not yet connected. With an IoT product, time-in-market provides much more essential feedback than ever before. Innovation comes from what you do with the data that the connected product provides in order to enhance the customer experience and optimize busi...
May. 5, 2016 06:00 AM EDT Reads: 1,350
In his session at 18th Cloud Expo, Sagi Brody, Chief Technology Officer at Webair Internet Development Inc., will focus on real world deployments of DDoS mitigation strategies in every layer of the network. He will give an overview of methods to prevent these attacks and best practices on how to provide protection in complex cloud platforms. He will also outline what we have found in our experience managing and running thousands of Linux and Unix managed service platforms and what specifically c...
May. 5, 2016 03:00 AM EDT Reads: 1,353